Deutsche Bank Analysts Give Draegerwerk AG & Co KGaA (DRW3) a €46.00 Price Target

Draegerwerk AG & Co KGaA (ETR:DRW3) has been given a €46.00 ($53.49) price target by research analysts at Deutsche Bank in a research note issued to investors on Tuesday, Borsen Zeitung reports. The firm currently has a “neutral” rating on the stock. Deutsche Bank’s target price suggests a potential downside of 13.62% from the stock’s current price.

Several other equities research analysts have also recently commented on DRW3. Warburg Research set a €49.00 ($56.98) price target on shares of Draegerwerk AG & Co KGaA and gave the stock a “neutral” rating in a research report on Tuesday, April 16th. Nord/LB set a €45.00 ($52.33) price target on shares of Draegerwerk AG & Co KGaA and gave the stock a “neutral” rating in a research report on Friday, April 26th. Independent Research set a €43.00 ($50.00) price target on shares of Draegerwerk AG & Co KGaA and gave the stock a “sell” rating in a research report on Monday. Kepler Capital Markets set a €44.00 ($51.16) price target on shares of Draegerwerk AG & Co KGaA and gave the stock a “sell” rating in a research report on Friday, January 11th. Finally, Hauck & Aufhaeuser set a €42.00 ($48.84) price target on shares of Draegerwerk AG & Co KGaA and gave the stock a “neutral” rating in a research report on Monday, March 11th. Two research analysts have rated the stock with a sell rating and five have issued a hold rating to the company. Draegerwerk AG & Co KGaA has a consensus rating of “Hold” and a consensus price target of €44.57 ($51.83).

Shares of ETR:DRW3 opened at €53.25 ($61.92) on Tuesday. Draegerwerk AG & Co KGaA has a one year low of €42.08 ($48.93) and a one year high of €73.00 ($84.88). The company has a quick ratio of 1.33, a current ratio of 2.04 and a debt-to-equity ratio of 22.92. The company has a market cap of $950.16 million and a PE ratio of 36.83.

Draegerwerk AG & Co KGaA Company Profile

Drägerwerk AG & Co KGaA develops equipment and solutions in the fields of medical and safety technology in Europe, Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care.

Read More: Why are analyst ratings important in trading stocks?

Analyst Recommendations for Draegerwerk AG & Co KGaA (ETR:DRW3)

Receive News & Ratings for Draegerwerk AG & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Draegerwerk AG & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.